Disease | rheumatoid arthritis |
Comorbidity | C0024314|lymphoproliferative disorder |
Sentences | 5 |
PubMedID- 23269079 | Successful treatment of immunodeficiency-associated ebv-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration. |
PubMedID- 24498893 | Objective: to investigate the incidence and clinical features of methotrexate (mtx)-related lymphoproliferative disorders (mtx-lpds) in patients with rheumatoid arthritis (ra). |
PubMedID- 21830047 | rheumatoid arthritis complicated with immunodeficiency-associated lymphoproliferative disorders during treatment with adalimumab. |
PubMedID- 23560463 | Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, epstein-barr virus, and clonality are important predictors of disease progression and regression. |
PubMedID- 24684409 | Pulmonary and retroperitoneal lesions induced by methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis. |
Page: 1